ESMO Adaptation of Lines of Systemic Therapy ( EnLiST): Evandro de Azambuja, MD, PhD Diogo Martins Branco ESMO - Eur. Oncology

What happens in Zurich….goes to #ESMO25 ! Fantastic meeting and discussions for the educations, together with my scientific co-chair Toni Choueiri, MD ! New tracks, new concepts and the best experts! Mark your agendas for #Berlin ! ESMO - Eur. Oncology

Brainstorming on EnLiST, the ESMO - Eur. Oncology ESMO Adaptation of Lines of Systemic Therapy, with Chris Twelves, Kamal Saini, Miriam Koopman, Suzette Delaloze, the ESMO Real World Data Digital Working Group and individual experts from EMA FDA Industry EORTC CRO Patient Advocates

➡️Secure your place now to stay up-to-date with the ongoing European efforts in digital health interoperability for an optimal clinical data exchange. Register now for this #DigitalOncology webinar: 🔗ow.ly/IzCW50Rj5tX

👉The last webinar in the #PrecisionOncology series is now available to the entire oncology community.
Access with your ESMO account: 🔗ow.ly/QbL750Rj8oz

Claudia Cardone Vivek Subbiah, MD Sewanti Limaye 🇮🇳🇺🇸 Ben Westphalen George Pentheroudakis

📢The ESMO - Eur. Oncology #PrecisionMedicine Working Group will 🔜 launch a new tool for screening #TumourAgnostic potential & a therapeutic effect #taxonomy as part of a proposed drug development framework ‼️
👉Stay tuned

ESMO Open (ESMO Open) is among the fastest growing journals in oncology. Consider submitting your data to the Open Access journal of ESMO - Eur. Oncology! journalinsights.elsevier.com/journals/2059-…

📣The last webinar in the #PrecisionOncology series presents ESMO’s new proposal for a classification of tissue-agnostic therapeutics. Register now:🔗ow.ly/8xBH50R8aFI

Claudia Cardone Vivek Subbiah, MD Sewanti Limaye 🇮🇳🇺🇸 Ben Westphalen George Pentheroudakis

📅 A unique opportunity to have your questions answered by world-renowned experts in #BreastCancer

Register now to enjoy this ESMO member benefit:
🔗ow.ly/ehpN50R4ZfI

#ESMODeepDive

📢New edition of ' #Lymphomas : Essentials for Clinicians' now available. This #ESMOBook is mainly addressed towards junior doctors but is also suitable for general oncologists or haematologists who want to stay updated. ow.ly/FGCt50R1lqk
Ivana Božović Raffaele Califano Tania Fleitas Kanonnikoff

ESMO Practicing Oncologist WG, Prague

Just out 📢 The new ESMO Living Guideline on Non-Oncogene-Addicted Metastatic Non-Small-Cell #LungCancer . Updated treatment algorithms & recommendations, directly linked to ESMO-MCBS scores & references, easily accessible on desktop & mobile devices. ow.ly/fTm250QWY2i

ESMO Sarcoma Rare Cancer Congress:
RCTs vs Pragmatic RCTs vs Synthetic Control arms, by D Lacombe

In un palazzo di via Ginevra ha la sede ESMO, con 35’000 associati. Solo la statunitense ASCO raccoglie un numero maggiore di oncologi medici. Un 'impero' nato a metà degli anni ’90 in un piccolo ufficio di Besso ticinoscienza.ch/it/news.php?da…

ESMO Educational Publications Working Group, Zurich

#ESMOGI24 : the Scientific Co-Chairs – Eric Van Cutsem, Ducreux Michel, Teresa Macarulla - look forward to receiving yr contributions & welcoming you to Munich for what promises to be an enlightening and impactful congress. 📣 Submit yr abstract by 9 Apr
🔗ow.ly/p71i50QJmGe

Scientific Co-Chairs, Eric Van Cutsem, Ducreux Michel & Teresa Macarulla, as well as members of the Scientific Committee & experts in the field, give their reasons why you should attend #ESMOGI24 , on 26-29 June, in Munich. Register by 10 April and save.
🔗ow.ly/K5hS50QBGO5

Great session this afternoon on #oncology #drug development 💉💊
#Biotech status & prospects
Fruitful live discussion & interaction
#ESMOTAT24

The abstract of the 15 February 2024 #ESMOVirtualPlenary is available in Annals of Oncology
👇
Event-free survival and overall survival of neoadjuvant tislelizumab (TIS) plus chemotherapy with adjuvant TIS in resectable NSCLC annalsofoncology.org/article/S0923-…
#LCSM ESMO - Eur. Oncology

#ESMODailyReporter : Perioperative tislelizumab improves survival in resectable #NSCLC – a new standard of care? Encouraging EFS & OS results presented at today's #ESMOVirtualPlenary for the use of the immune checkpoint inhibitor before & after surgery.

ow.ly/iSRe50QC79s?